Natural Product: NPC104138

Natural Product IDNPC104138
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(2E,4E)-N-Isobutyleicosa-2,4-Dienamide
IUPAC Name (2E,4E)-N-(2-methylpropyl)icosa-2,4-dienamide
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2347638
PubChem CID 6441067
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0000331] Fatty amides
          • [CHEMONTID:0001096] N-acyl amines

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LMZPUHBJSQVRHE-HYGARKJASA-N
Standard InCHI InChI=1S/C24H45NO/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-24(26)25-22-23(2)3/h18-21,23H,4-17,22H2,1-3H3,(H,25,26)/b19-18+,21-20+
SMILES CCCCCCCCCCCCCCC/C=C/C=C/C(=NCC(C)C)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   363.35 Volume:   435.538
?
Van der Waals volume.
Dense:   0.834 LogP:   7.838
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.262
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.49
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   18.0 Rigid Bonds:   3.0
TPSA:   32.59
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   1.0 Rings:   0.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.113 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.792 Fsp3:   0.792
MCE-18:   0.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.682 Fluc inhibitor:   0.635
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.002
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.1
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.452 Promiscuous compounds:   0.061

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.025 MDCK Permeability:   -4.786
Pgp-inhibitor:   0.026 Pgp-substrate:   0.08
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.243
20% Bioavailability (F20%):   0.931 30% Bioavailability (F30%):   0.999
50% Bioavailability (F50%):   0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.606
Plasma Protein Binding (PPB):   98.633% Volume Distribution (VD):   0.685
Fu: 1.041%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.955
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.655
BSEP inhibitor:   0.999

ADMET: Metabolism

CYP1A2-inhibitor:   0.253 CYP1A2-substrate:   0.999
CYP2C19-inhibitor:   0.864 CYP2C19-substrate:   0.988
CYP2C9-inhibitor:   0.629 CYP2C9-substrate:   0.981
CYP2D6-inhibitor:   0.713 CYP2D6-substrate:   0.284
CYP3A4-inhibitor:   0.934 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.089 CYP2C8-inhibitor:   1.0
HLM stability:   0.218
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.42 Half-life (T1/2):  0.578

ADMET: Toxicity

hERG Blockers:  0.405 hERG Blockers (10um):  0.601
Human Hepatotoxicity (H-HT):  0.926 Drug-induced Liver Injury (DILI):  0.728
AMES Toxicity:  0.414 Rat Oral Acute Toxicity:  0.339
Maximum Recommended Daily Dose:  0.366 Skin Sensitization:  0.999
Carcinogencity:  0.677 Eye Corrosion:  0.262
Eye Irritation:  0.966 Respiratory Toxicity:  0.969
Drug-induced Neurotoxicity:  0.064 Ototoxicity:  0.387
Hematotoxicity:  0.217 Drug-induced Nephrotoxicity:  0.704
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.022
A549 Cytotoxicity:  0.382 Hek293 Cytotoxicity:  0.243
BCF:   1.157
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.2
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.508
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.49
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26237 Piper longum Species Piperaceae Eukaryota n.a. n.a. n.a. PMID[16872768]
NPO26237 Piper longum Species Piperaceae Eukaryota fruits n.a. n.a. PMID[20839888]
NPO26237 Piper longum Species Piperaceae Eukaryota n.a. n.a. n.a. PMID[23434420]
NPO26237 Piper longum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO26237 Piper longum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26237 Piper longum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26237 Piper longum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO26237 Piper longum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO26237 Piper longum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT963 Organism Hepatitis B virus Hepatitis B virus IC50 = 1070000.0 nM PMID[23434420]
NPT963 Organism Hepatitis B virus Hepatitis B virus IC50 = 580000.0 nM PMID[23434420]
NPT2 Others Unspecified n.a. Ratio CC50/IC50 = 1.5 n.a. PMID[23434420]
NPT2 Others Unspecified n.a. Ratio CC50/IC50 = 2.7 n.a. PMID[23434420]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC104138 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC273023
1.0 High Similarity NPC24216
1.0 High Similarity NPC306420
0.9697 High Similarity NPC261158
0.9688 High Similarity NPC195986
0.9118 High Similarity NPC303672
0.7714 Intermediate Similarity NPC243539
0.7429 Intermediate Similarity NPC145032
0.7429 Intermediate Similarity NPC307435
0.7429 Intermediate Similarity NPC304223
0.7429 Intermediate Similarity NPC54542
0.7317 Intermediate Similarity NPC187315
0.7222 Intermediate Similarity NPC267340
0.6923 Remote Similarity NPC312826
0.6585 Remote Similarity NPC297020
0.6486 Remote Similarity NPC267692
0.6429 Remote Similarity NPC119655
0.6429 Remote Similarity NPC471992
0.6341 Remote Similarity NPC167759
0.6341 Remote Similarity NPC56028
0.6341 Remote Similarity NPC123669
0.619 Remote Similarity NPC6795
0.6047 Remote Similarity NPC305288
0.6047 Remote Similarity NPC163912
0.5581 Remote Similarity NPC13011
0.5581 Remote Similarity NPC124382
0.5526 Remote Similarity NPC245650
0.5172 Remote Similarity NPC41331
0.5172 Remote Similarity NPC291449

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC104138 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data